AAM praises generics’ role in Trump pricing plan
In a move that’s considered an “important step forward for patients coping with skyrocketing health care costs,” Association for Accessible Medicines president and CEO Chester “Chip” Davis, Jr., praised President Trump for making clear in his remarks on Friday the important role that generic and biosimilar medicines play in containing prescription drug costs for patients.